Mitsuha Hayashi

491 total citations
11 papers, 305 citations indexed

About

Mitsuha Hayashi is a scholar working on Immunology, Dermatology and Rheumatology. According to data from OpenAlex, Mitsuha Hayashi has authored 11 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Dermatology and 3 papers in Rheumatology. Recurrent topics in Mitsuha Hayashi's work include Psoriasis: Treatment and Pathogenesis (6 papers), Dermatology and Skin Diseases (6 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Mitsuha Hayashi is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (6 papers), Dermatology and Skin Diseases (6 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Mitsuha Hayashi collaborates with scholars based in Japan. Mitsuha Hayashi's co-authors include Hidemi Nakagawa, Yoshinori Umezawa, Hidehisa Saeki, Koichi Yanaba, Toshihiro Ito, Osamu Fukuchi, Yuki Yoshihara, Sota Kikuchi, Yoshimasa Nobeyama and Yozo Ishiuji and has published in prestigious journals such as Journal of Dermatological Science, Archives of Dermatological Research and The Journal of Dermatology.

In The Last Decade

Mitsuha Hayashi

11 papers receiving 301 citations

Peers

Mitsuha Hayashi
Lieke J. van Vugt Netherlands
M. Krensel Germany
Marie Teil United Kingdom
Adam Berlinberg United States
Mitsuha Hayashi
Citations per year, relative to Mitsuha Hayashi Mitsuha Hayashi (= 1×) peers Véronique Lamarque

Countries citing papers authored by Mitsuha Hayashi

Since Specialization
Citations

This map shows the geographic impact of Mitsuha Hayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuha Hayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuha Hayashi more than expected).

Fields of papers citing papers by Mitsuha Hayashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuha Hayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuha Hayashi. The network helps show where Mitsuha Hayashi may publish in the future.

Co-authorship network of co-authors of Mitsuha Hayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuha Hayashi. A scholar is included among the top collaborators of Mitsuha Hayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuha Hayashi. Mitsuha Hayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Asahina, Akihiko, et al.. (2017). Biologic treatments for elderly patients with psoriasis. The Journal of Dermatology. 44(9). 1020–1023. 24 indexed citations
2.
Yoshihara, Yuki, Koichi Yanaba, Mitsuha Hayashi, et al.. (2017). IL-10-producing regulatory B cells are decreased in patients with atopic dermatitis and are inversely correlated with disease severity. Journal of Dermatological Science. 86(2). e26–e26. 1 indexed citations
3.
Hayashi, Mitsuha, Koichi Yanaba, Yoshinori Umezawa, Akihiko Asahina, & Hidemi Nakagawa. (2017). Impact of anti‐tumor necrosis factor‐α agents on serum levels of KL‐6 and surfactant protein‐D in patients with psoriasis. The Journal of Dermatology. 44(9). 1063–1066. 9 indexed citations
4.
Yanaba, Koichi, Mitsuha Hayashi, Yuki Yoshihara, & Hidemi Nakagawa. (2016). Serum levels of soluble programmed death‐1 and programmed death ligand‐1 in systemic sclerosis: Association with extent of skin sclerosis. The Journal of Dermatology. 43(8). 954–957. 39 indexed citations
5.
Yanaba, Koichi, et al.. (2016). Clinical significance of serum soluble T‐cell immunoglobulin and mucin domain 3 levels in systemic sclerosis: Association with disease severity. The Journal of Dermatology. 44(2). 194–197. 14 indexed citations
6.
Hayashi, Mitsuha, Koichi Yanaba, Yoshinori Umezawa, et al.. (2015). IL-10-producing regulatory B cells are decreased in patients with psoriasis. Journal of Dermatological Science. 81(2). 93–100. 57 indexed citations
7.
Umezawa, Yoshinori, Mitsuha Hayashi, Sota Kikuchi, et al.. (2015). Ustekinumab treatment in patients with psoriasis undergoing hemodialysis. The Journal of Dermatology. 42(7). 731–734. 14 indexed citations
8.
Yanaba, Koichi, Yoshinori Umezawa, Toshihiro Ito, et al.. (2014). Impact of obesity on the efficacy of ustekinumab in Japanese patients with psoriasis: a retrospective cohort study of 111 patients. Archives of Dermatological Research. 306(10). 921–925. 21 indexed citations
10.
Hayashi, Mitsuha, Yoshinori Umezawa, Osamu Fukuchi, et al.. (2014). Efficacy and safety of ustekinumab treatment in elderly patients with psoriasis. The Journal of Dermatology. 41(11). 974–980. 66 indexed citations
11.
Umezawa, Yoshinori, Yoshimasa Nobeyama, Mitsuha Hayashi, et al.. (2013). Drug survival rates in patients with psoriasis after treatment with biologics. The Journal of Dermatology. 40(12). 1008–1013. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026